Tony Liu, CEO, CFO at Cellular Biomedicine Group, Inc. (CBMG), bought 10,000 shares at $6.81 ($68K) on 2017-06-06, disclosed to the SEC on 2017-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.78 | 100 | $678 | 1.0% |
| 2 | $6.80 | 800 | $5K | 8.0% |
| 3 | $6.81 | 800 | $5K | 8.0% |
| 4 | $6.83 | 2,000 | $14K | 20.0% |
| 5 | $6.84 | 1,200 | $8K | 12.0% |
| 6 | $6.84 | 2,100 |
| $14K |
| 21.0% |
| 7 | $6.85 | 2,900 | $20K | 29.1% |
| 8 | $6.85 | 100 | $685 | 1.0% |
| Total | $6.83 avg | 10,000 | $68K | 100% |
| Filing → |
| CBMG | BUY | 2013-04-17 | $4K | — | Filing → |
| AOB | BUY | 2007-03-16 | $189K | — | Filing → |
| AOB | BUY | 2007-03-15 | $260K | — | Filing → |